Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
14.39
+0.86 (6.36%)
At close: May 12, 2025, 4:00 PM
14.39
0.00 (0.00%)
After-hours: May 12, 2025, 7:55 PM EDT
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $1.72 billion as of May 12, 2025. Its market cap has increased by 70.51% in one year.
Market Cap
1.72B
Enterprise Value
1.63B
1-Year Change
70.51%
Ranking
Category
Stock Price
$14.39
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $1.72B, an increase of 119.34%. That is a compound annual growth rate of 16.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 1.61B | -1.08% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | 1.23B | 56.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |